Business Context and Reporting Period
This Form 8-K filing by Bruker Corporation (BRUKER CORP) was submitted on November 5, 2009. The report details significant changes to the executive management team approved by the Board of Directors, effective February 1, 2010, along with immediate adjustments to compensation and equity awards.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes and associated compensatory arrangements.
Material Changes
- Executive Role Changes: William J. Knight will transition from Chief Financial Officer to Chief Operating Officer. Brian P. Monahan will be promoted from Chief Accounting Officer and Vice President of Finance to Chief Financial Officer.
- Compensation Adjustments:
- Mr. Knight's annual salary increased from $288,000 to $355,000.
- Mr. Monahan's annual salary increased from $180,000 to $275,000.
- Both increases are effective immediately.
- Equity Grants:
- Mr. Knight received options to purchase 50,000 shares of common stock.
- Mr. Monahan received options to purchase 100,000 shares of common stock.
- Options were granted on November 5, 2009, at the closing price on that date, with a five-year vesting schedule.
- Severance Agreements: New agreements entitle both officers to severance payments equal to six months' salary in the event of termination without cause.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of risks and contingencies related to the company's operations or market conditions. The primary focus is the execution of the management transition plan.
Key Facts for Investor Verification
- Verify the effective date of the role transition (February 1, 2010) versus the immediate effective date of salary increases.
- Confirm the vesting schedule details for the 150,000 total stock options granted to the two executives.
- Review the attached press release (Exhibit 99.1) for additional context on the strategic rationale for these changes.
- Note that the filing does not disclose the specific strike price of the options, only that it was the closing price on the grant date.